chrisvoncsefalvay/vaers-outcomes huggingface dataset:
21 yo male had the Moderna vaccine 1.5 weeks ago and 3 days ago he was lifting light and last hs he got pain and swelling to the left upper back above the scapula.  He has 10/10 pain.  he has been icing it.  He did not lift heavy when working out and did not feel a pull or twinge.  It was his first vaccine in the series. Physical exam: He has 4 cm area of tenderness and swelling to the left upper back, above the scapula.  Pain with abduction of the left arm.  No pain in shoulder joint or swelling.
Scaly painful sometimes itchy, episodic rash on hands. Still continues as of current time significantly effecting my ability to do my work due to requiring hand washing and wearing of gloves etc., that cause significant pain.
red rash on back, stomach, arms and legs, and rash is slightly raised, concentrated of red; rash is warm to touch; Sore arm; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of RASH PAPULAR (red rash on back, stomach, arms and legs, and rash is slightly raised, concentrated of red), SKIN WARM (rash is warm to touch), PAIN IN EXTREMITY (Sore arm) and FATIGUE (fatigue) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     The patient's past medical history included Rash (reported she has noticed that when she has something going on with her immune system, she has had rashes in the past).    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, the patient experienced RASH PAPULAR (red rash on back, stomach, arms and legs, and rash is slightly raised, concentrated of red), SKIN WARM (rash is warm to touch), PAIN IN EXTREMITY (Sore arm) and FATIGUE (fatigue). The patient was treated with FAMOTIDINE (PEPCID AC) for Adverse event, at an unspecified dose and frequency; FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for Adverse event, at an unspecified dose and frequency; QUERCETIN for Adverse event, at an unspecified dose and frequency and URTICA DIOICA ROOT (STINGING NETTLE ROOT) for Adverse event, at an unspecified dose and frequency. At the time of the report, RASH PAPULAR (red rash on back, stomach, arms and legs, and rash is slightly raised, concentrated of red), SKIN WARM (rash is warm to touch), PAIN IN EXTREMITY (Sore arm) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment for the events included Allegra, Pepcid, querstine, and stinging nettle (over the counter medicine). Concomitant medication was not reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded
Cellulitis (R) thigh injection site 13x18cm, fever. Oral Clindamycin (prescribed at 3/27/08 office visit). IV Vancomycin, Ancef (admitted to hospital 3/27/08-3/31/08). Rocephin IM, Bactrim PO (admitted to hospital 4/1/08 - 4/2/08). 5/12/2008 MR received for DOS 3/27-29/2008 with DX: Cellulitis. Pt presented with enlarging R thigh erythema which was tender to palpation and warm. Pt had temp of 100.5. Tx with vanco and sent home on clindamycin.  04/15/2008 MR received for DOS 4/1-2/2008 with D/C DX:  R thigh Cellulits-improving.  Vomiting.  Diarrhea.  Obesity.  Also seen in ER 1 day prior for same and D/c'd.  Pt presented with 4 day hx of vomiting and blood streaked diarrhea which began after starting po abx for R thigh Cellulitis for which pt had been admitted to another hospital.   Pt unable to keep Clindamycin down.  PE WNL.
PT RECEIVED 1ST DOSE OF PFIZER VACCINE, APPROXIMATELY 5 MINUTES AFTER RECEIVING VACCINE, PT WAS HAVING SEIZURE LIKE ACTIVITY. EMS WAS CALLED IMMEDIATELY. PT REMAINED IN A TONIC/CLONIC STATE FOR APPROXIAMTELY 45 SECONDS. PT REGAINED CONSCIOUSNESS AND WAS ADVISED OF WHAT HAPPENED. BP WAS 150/80, PULSE 68, RR-16, SPO2%-98%. PT WAS ALERT TO NAME, DATE, MONTH AND YEAR ONCE HE CAME TO. PT STATED THAT HE HAD NO MEDICATION HX OR HX OF GOING TO THE DOCOR IN OVER 18 YEARS. PT WAS TRANSPORTED VIA EMS TO LOCAL HOSPITAL.
Swollen lymph node on neck on same side; Painful lymph node on neck on same side; This is a spontaneous report from a non-contactable consumer, the patient. An unspecified aged non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN), via an unspecified route of administration on an unspecified date in 2021 as a single dose for COVID-19 immunisation. The patient had history of known allergies to eggs. The patient did not take any concomitant medication. The patient previously took sulphur (MANUFACTURER UNKNOWN) on unknown date for an unspecified indication and experienced drug allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On an unspecified date in 2021, the patient experienced swollen painful lymph node on neck on same side where injected. No therapeutic measures were taken as the result of adverse events. The adverse event did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event swollen painful lymph node on neck on same side where injected was not recovered at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
dropping my pulse to 41, 40, 42; weight loss; loss of taste smell; loss of taste smell; fever; blood pressure was 100/60 or 90/55; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (COMIRNATY), dose 2 via an unspecified route of administration on 14Aug2021 (Batch/Lot number was not reported) as dose 2, single for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccine included first dose of Comirnaty on 23Jul2021 for Covid-19 Immunization. On an unspecified date in 2021, the patient experienced weight loss, loss of taste smell, fever, dropping my pulse to 41, 40, 42, and blood pressure was 100/60 or 90/55. The patient reported she had terrible side effects from the shots. She got her second one and it all gone worse. The patient reported that she had emergency change for her heart medicine (Unspecified Medication) because they were certainly way too strong, dropping my pulse to 41, 40, 42. Her blood pressure was 100/60 or 90/55 and she was basically dying at home (as reported). The patient added that she was losing weight and could not taste or smell anything, and fever. She mentioned that she was in the hospital (pending clarification). The patient reported, "In Mar2020 (as reported-pending clarification), I was losing weight, I could not taste or smell anything, I had a raging fever, and it was spiking back and forth, and I said I do not get a fever very frequently actually". The outcome of events was unknown.  The lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Skin plaque/Plaques flare up on shins/head/buttocks/elbows and arms; Ache; Fatigue; Pain in arm/Sore arm; Interchange of vaccine products; Revaccination with different COVID-19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of SKIN PLAQUE (Skin plaque/Plaques flare up on shins/head/buttocks/elbows and arms), PAIN (Ache), FATIGUE (Fatigue), PAIN IN EXTREMITY (Pain in arm/Sore arm) and INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect products included non-company products TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination and RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) for an unknown indication.    No Medical History information was reported.   On 20-Jun-2021, the patient received first dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (Intramuscular) 1 dosage form. On 20-Jul-2021, received second dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) dosage was changed to 1 dosage form. On 20-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced SKIN PLAQUE (Skin plaque/Plaques flare up on shins/head/buttocks/elbows and arms), PAIN (Ache), FATIGUE (Fatigue), PAIN IN EXTREMITY (Pain in arm/Sore arm), INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) and COVID-19 IMMUNISATION (Revaccination with different COVID-19 vaccine). At the time of the report, SKIN PLAQUE (Skin plaque/Plaques flare up on shins/head/buttocks/elbows and arms) had not resolved and PAIN (Ache), FATIGUE (Fatigue), PAIN IN EXTREMITY (Pain in arm/Sore arm), INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) and COVID-19 IMMUNISATION (Revaccination with different COVID-19 vaccine) outcome was unknown.            This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.  No concomitant medication was provided. No treatment medication was provided. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. The reporter's causality for the events of plaques flare up on shins/head/buttocks/elbows and arms with  SKYRIZI(RISANKIZUMAB) was a reasonable possibility. The reporter's causality for the events of fatigued, sore arm and ACHY with SKYRIZI(RISANKIZUMAB) was no reasonable possibility.
Volunteer (Vol) had Tdap on 10-22-13 had typical soreness. On 10-25-13 started to feel "a sensation" that continued. This AM had a rash of (L) deltoid area - where injection given. Sent to own PCP for eval.: local reaction to Tdap - vs - Shingles outbreak.
PATIENT SAYS INJECTION SITE BEGAN ITCHING YESTERDAY AND NOW A RASH HAS APPEARED WITH SLIGHT SWELLING
I originally started to have sore joints starting in the left arm that shot was administered around 8:00 PM. Around 9:00, my joints were sore all over. Around 10:00, I started to have mild sharp pain in my joints all over. I fell asleep around 10:00 PM and woke up around 12:00 AM 2/04/14 to horrible chill and severe sharp stabbing joint pain. I took my temperature and had a fever of 103.2. This went on throughout the night. When I was finally able to get out of bed at around 11, I called the hospital number and they scheduled me in with my doctor for 2:40 PM on 2/04/14. At first they thought it was the flu, but was confused after that test came back negative. They took my temperature at 102 degrees when I was seen. They don't know if it is an adverse reaction since it was rare. They told me to go back in if it gets worse. I've been taking Ibuprofen and it hasn't helped with reducing my fever. As of today, 2/05/14, I still have a fever of 102 and sore stabbing pain in my joints.
Circular red spot (area), warm to touch, firm, tender, about 3 inches diameter.   Lasted 5-6 days.
This spontaneous report was received from a licensed practical nurse concerning a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant therapies, drug reactions or allergies were not reported. On 22-OCT-2015, the patient was accidentally vaccinated with an expired dose of M-M-R II lot # J013069, expiration date 16-OCT-2015, (dose, dose number, route and anatomical location were unspecified). No adverse effects reported. Additional information has been requested.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a non-contactable reporter (Consumer). The reporter is the patient. A 33-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 30Sep2022 as dose 5 (booster), single (Lot number: gh9702) at the age of 32 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Blood cancer" (unspecified if ongoing), notes: blood cancer age 11; "Chemo" (unspecified if ongoing), notes: Chemo; "Radiation to chest" (unspecified if ongoing), notes: Radiation to chest; "Thyroidectomy" (unspecified if ongoing), notes: at age 24; "Papillary carcinoma" (unspecified if ongoing), notes: papillary carcinoma age 24.  The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Mar2023, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Mar2023) Positive.  Therapeutic measures were taken as a result of drug ineffective, covid-19 includes Paxlovid.   No follow-up attempts are possible. No further information is expected.
radiating myalgia; right arm muscle soreness; pain; minor headache; fatigue; chills; night sweats; mild fever; This is a spontaneous report received from a contactable consumer or other non hcp.A 31-years-old female patient received 2nd dose of bnt162b2 (Pfizer-covid19 vaccine,Batch/Lot Number: EL3247; Expiration Date: May2021),via an unspecified route of administration, administered in Arm Left on 17Feb2021 21:15,at the age of 31 years old, as Dose 2,single for covid-19 immunization.The patient medical history was not reported. Concomitant medications included sertraline hydrochloride (ZOLOFT) taken for an unspecified indication, start and stop date were not reported.The patient experienced radiating myalgia, right arm muscle soreness, pain, minor headache , fatigue, chills, night sweats, mild fever on 18Feb2021 12:00 with outcome of recovering.The patient underwent lab tests and procedures which included pyrexia: 99.5 degrees on 18Feb2021.The patient previously received her 1st dose of Pfizer covid19 vaccine on 26 jan2021,02:00 am.The patient had not been diagnosed with covid19 vaccine prior to vaccination and not tested for covid19 post vaccination.The patient had not received any treatment for the event.The outcome of the event was recovering.  Follow-up (14MAY2021): Follow-up attempts completed. No further information expected.
Blurry vision and a dimness OS in the upper portion of her vision;  Patches of lightness/darkness OS. Branch Retinal Vein Occlusion OS
very swollen lymph node in neck, above clavicle toward the neck, left side (side of vaccination).  Getting bigger every day for 4 days now.  Overall soreness of shoulder (despite not having much injection site soreness the days after the shot)
Vaccine was expired on 01-Apr-2022, refrigerated on 04-Apr-2022 and administered on 08-Apr-2022; Vaccine was expired on 01-Apr-2022 administered on 08-Apr-2022; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 01-Apr-2022 administered on 08-Apr-2022) and PRODUCT STORAGE ERROR (Vaccine was expired on 01-Apr-2022, refrigerated on 04-Apr-2022 and administered on 08-Apr-2022) in an 81-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 08-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 01-Apr-2022 administered on 08-Apr-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was expired on 01-Apr-2022, refrigerated on 04-Apr-2022 and administered on 08-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 01-Apr-2022 administered on 08-Apr-2022) and PRODUCT STORAGE ERROR (Vaccine was expired on 01-Apr-2022, refrigerated on 04-Apr-2022 and administered on 08-Apr-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  The vial was initially stored in the refrigerator on 04-Apr-2022. The vial did not undergo any temperature excursions. It was reported that pharmacist thought that the vaccine was expired in Jun-2022, however it was expired on 01-Apr-2022.  No treatment information was reported
This spontaneous report was received from a pharmacist refers to a patient of unknown age and gender. Medical history and concurrent conditions were not reported. the pharmacist informed, that the patient received two doses of ZOSTAVAX (route, dosage, lot# and expiration date were not reported). Concomitant therapy was not reported. One dose was administered on an unknown date in 2014 (also reported as last year), and the other dose was administered on an unspecified date in 2015 (also report as this year), the pharmacist did no report adverse effects. The patient contacted the pharmacist looking for medical attention. Additional information has been requested.
Aphtha; muscle pain on his left deltoid bicep, left upper arm, the same site where he got the vaccine; Strange amount of fatigue in arm where vaccine was administered/ Caller would say it is persisting and has also worsened; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-202101240940 (Pfizer).  A 23 year-old male patient received bnt162b2 (BNT162B2), administered in deltoid left, administration date 17Sep2021 14:00 (Lot number: FC3183) at the age of 23 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: FATIGUE (non-serious) with onset 21Sep2021, outcome "unknown", described as "Strange amount of fatigue in arm where vaccine was administered/ Caller would say it is persisting and has also worsened"; APHTHOUS ULCER (non-serious), outcome "unknown", described as "Aphtha"; MYALGIA (non-serious), outcome "unknown", described as "muscle pain on his left deltoid bicep, left upper arm, the same site where he got the vaccine".  Additional information: patient did not receive any other vaccine within four weeks prior to the first administration date of the suspect vaccine. patient reported massaging the area as well but was not able to resolve it. He also reported that around the same day he got the vaccine he developed mouth ulcer or what he labeled as "Aphtha" on his left inner teeth (Same side where he got the vaccine).  No follow-up attempts are possible. No further information is expected.
26MAR92 mom states pt has dime-sized induration on tongue; onset this afternoon; states area reddened, painful also fever; 27MAR92 to ER last noc; Rx meds for cough & rt ear infect;
4/20/07 Child received vaccinations at 2 mo visit on 4/16/07. On 4/20/07 around 1 am the mother breast fed baby and put her in the bed between parents. When parents awake at 7 am the baby was unresponsive and cold. Taken to hospital ER where they were unable to revive her. ? SIDS  4/27/07 Received medical records from PCP which reveal patient experienced good health on day of vax.  Vax record confirmed RO lot number as reported on VAERS report.  7/11/07-ME report received. COD:Sudden Infant Death Syndrome while co-sleeping w/2 adults.
Given DTap in L leg 11/9/05.  On 11/11/05 returned to office with rash that was warm and swollen on L thigh and right hip.  Some hives on R hip.  Dr. prescribed Benadryl prn and Tylenol prn.
04/06/21 hot hard bump at injection site, spot on back itching and burning began to grow, spread across entire body ongoing red patches at injection site
In the weeks following, I had shortness of breath, dizziness when going activity, which is new. I also had worse migraines. Still experiencing of shortness of breath varying between several months. Ended up in hospital on 10/23/2022 at a local hospital for chest pain and nausea, shortness of breath and did not find anything. I will be getting tests from cardiologist in December.
death N17.9 - AKI (acute kidney injury) (CMS/HCC) J96.01 - Acute respiratory failure with hypoxia (CMS/HCC)
continuous crying not able to calm, immunization this AM; seen by MD in PM; given DPH; prescription for Motrin x 2 days; large hard knot to lt thigh;
a patient / only received the first dose. It has been at least 1 year; This case was reported by a other health professional via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on unknown date, atleast 1 year prior to reporting).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, patient did not received 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter mentioned that, it has been atleast one year, patient has received 1st dose of Shingrix. The reporter asked if patient should start over and do 2 doses or just give a booster. This case has been linked with US2021AMR134422, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR134422:Same reporter
Raynaud's disease; Vaccination site pain; This spontaneous case was reported by a non-health professional and describes the occurrence of RAYNAUD'S PHENOMENON (Raynaud's disease) and VACCINATION SITE PAIN (Vaccination site pain) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product UPADACITINIB (RINVOQ) for Rheumatoid arthritis.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and UPADACITINIB (RINVOQ) (Oral) at an unspecified dose. On an unknown date, the patient experienced RAYNAUD'S PHENOMENON (Raynaud's disease) and VACCINATION SITE PAIN (Vaccination site pain). At the time of the report, RAYNAUD'S PHENOMENON (Raynaud's disease) had not resolved and VACCINATION SITE PAIN (Vaccination site pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was provided. The hands of the patient turned purple and had Raynaud's which was a long term chronic condition. She had soreness in arm after covid vaccination. It was unknown if patient was enrolled in a covid-19 vaccine trial. No treatment medication was provided. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
1/28/22 developed start of MIS-C.  diagnosis of MIS-C on 2/3/22.  mother has COVID-19 infection 1/1/22.